CH672988A5 - - Google Patents

Download PDF

Info

Publication number
CH672988A5
CH672988A5 CH1766/86A CH176686A CH672988A5 CH 672988 A5 CH672988 A5 CH 672988A5 CH 1766/86 A CH1766/86 A CH 1766/86A CH 176686 A CH176686 A CH 176686A CH 672988 A5 CH672988 A5 CH 672988A5
Authority
CH
Switzerland
Prior art keywords
gsh
cisplatin
aap
nag
grams
Prior art date
Application number
CH1766/86A
Other languages
English (en)
Italian (it)
Inventor
Odoardo Tofanetti
Roberto Assereto
Ennio Cavalletti
Sergio Tognella
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Publication of CH672988A5 publication Critical patent/CH672988A5/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1766/86A 1985-05-06 1986-04-30 CH672988A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20591/85A IT1200467B (it) 1985-05-06 1985-05-06 Formulazione farmaceutica

Publications (1)

Publication Number Publication Date
CH672988A5 true CH672988A5 (fr) 1990-01-31

Family

ID=11169266

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1766/86A CH672988A5 (fr) 1985-05-06 1986-04-30

Country Status (11)

Country Link
BE (1) BE904717A (fr)
CH (1) CH672988A5 (fr)
DE (1) DE3615313A1 (fr)
FR (1) FR2581312B1 (fr)
GB (1) GB2174905B (fr)
HK (1) HK69890A (fr)
IT (1) IT1200467B (fr)
LU (1) LU86414A1 (fr)
NL (1) NL8601157A (fr)
SE (1) SE8602060L (fr)
SG (1) SG62190G (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01203334A (ja) * 1988-02-08 1989-08-16 Mochida Pharmaceut Co Ltd 白金を含有する薬剤の副作用軽減剤
DE59103442D1 (de) * 1990-08-20 1994-12-08 Ohlenschlaeger Gerhard Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
US5925620A (en) * 1990-08-20 1999-07-20 Ohlenschlaeger; Gerhard Therapeutically active mixture of glutathione and anthocyanin compounds
ITMI20052449A1 (it) 2005-12-22 2007-06-23 Cell Therapeutics Europe Srl Nuovi bis-platino complessi ad attivita' antitumorale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3866M (fr) * 1964-07-08 1966-01-24 Rocal Médicament a base de dérivé du pyrocatéchol.
GB1110392A (en) * 1964-09-28 1968-04-18 Yamanouchi Pharma Co Ltd Composition containing glutathione and an amino acid or amino acids, and salts thereof
EP0087865B1 (fr) * 1982-03-01 1986-10-01 Efamol Limited Composition pharmaceutique

Also Published As

Publication number Publication date
IT8520591A0 (it) 1985-05-06
HK69890A (en) 1990-09-14
BE904717A (nl) 1986-09-01
LU86414A1 (fr) 1986-09-02
SE8602060D0 (sv) 1986-05-05
NL8601157A (nl) 1986-12-01
GB2174905A (en) 1986-11-19
GB8610970D0 (en) 1986-06-11
GB2174905B (en) 1989-09-20
SE8602060L (sv) 1986-11-07
FR2581312A1 (fr) 1986-11-07
SG62190G (en) 1990-09-07
DE3615313A1 (de) 1986-11-20
FR2581312B1 (fr) 1992-05-29
IT1200467B (it) 1989-01-18

Similar Documents

Publication Publication Date Title
Ross-Lee et al. Aspirin pharmacokinetics in migraine. The effect of metoclopramide
Sanjay et al. Midazolam: an effective antiemetic after cardiac surgery—a clinical trial
BR0116945A (pt) Uma preparação para prevenção de restenose
HUP0300218A2 (hu) Eljárás diabetes kezelésére, metformin és glybarid kombinációját alkalmazva
O'Reilly Comparative interaction of cimetidine and ranitidine with racemic warfarin in man
Fontana et al. Direct oral anticoagulants: a guide for daily practice
JP5161472B2 (ja) 鎮痛用組成物
Eichelbaum et al. Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.
CH672988A5 (fr)
CA2166704C (fr) Medicaments a l'arsenic pour le traitement du syndrome de fatigue chronique
Lui et al. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs
Rey et al. Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration
EP2830605B1 (fr) Combinaison médicamenteuse comprenant la phényléphrine et le paracétamol
US5292497A (en) Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate
Bullingham et al. An oral buprenorphine and paracetamol combination compared with paracetamol alone: a single dose double‐blind postoperative study.
Wang et al. Effect of diallyl trisulfide on the pharmacokinetics of dipyridamole in rats
Rajakulasingam et al. Effect of thromboxane A2-receptor antagonist on bradykinin-induced bronchoconstriction in asthma
Delarue et al. Effect of chemotherapy on resting energy expenditure in patients with non‐Hodgkin's lymphoma results of a sequential study
Suarez et al. Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy
Anand et al. Incidence and spectrum of electrolyte disturbances in cisplatin based chemotherapy
KR20150143504A (ko) 약물 및 영양 보조식품의 생체이용률을 증진시키기 위한 방법 및 생성물
US4810707A (en) Herpes simplex treatment
Talke et al. Dose-response study of oral famotidine for reduction of gastric acidity and volume in outpatients and inpatients
Dunk et al. The safety and efficacy of tripotassium dicitrato bismuthate (De‐Nol) maintenance therapy in patients with duodenal ulceration
Kivistö et al. Effect of activated charcoal on the absorption of amiodarone

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: BOEHRINGER MANNHEIM ITALIA S.P.A.

PL Patent ceased